All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Recovery comparison

GHK-Cu (Oral) vs TB-500

An educational, source-based comparison of GHK-Cu (Oral) and TB-500 — how each peptide works, what it's researched for, and what to know before going deeper.

Systemic · Regeneration
GHK-Cu (Oral)

Oral formulation of GHK-Cu for systemic regenerative research.

Mechanism

An oral formulation of the GHK-Cu tripeptide designed for systemic absorption. Research suggests the same copper-complex gene-modulating activity as topical forms, potentially supporting systemic tissue repair, immune modulation, and antioxidant capacity.

Research areas
  • Systemic tissue repair and regeneration
  • Immune modulation and inflammation
  • Lung and gut tissue health
  • Age-related gene expression restoration
Considerations
  • Oral bioavailability is lower than injectable; optimal dosing unclear.
  • Not FDA-approved for therapeutic use.
Full GHK-Cu (Oral) profile →
Tissue Repair · Vascular
TB-500

Synthetic fragment of Thymosin Beta-4 studied for tissue and vascular repair.

Mechanism

A synthetic peptide fragment of Thymosin Beta-4 (Tβ4). Research suggests it upregulates actin, promotes cell migration, angiogenesis, and modulates inflammation — supporting repair in muscle, tendon, cardiac, and corneal tissue models.

Research areas
  • Muscle and tendon repair
  • Cardiac tissue recovery (preclinical)
  • Corneal and dermal wound healing
  • Hair follicle stem cell activation
Considerations
  • Not FDA-approved; banned by WADA.
  • Most evidence is preclinical.
Full TB-500 profile →

GHK-Cu (Oral) vs TB-500 — Key differences

  • Class: GHK-Cu (Oral) is classified as Systemic · Regeneration, while TB-500 is Tissue Repair · Vascular.
  • Primary research focus: GHK-Cu (Oral)systemic tissue repair and regeneration; TB-500muscle and tendon repair.
  • Tag: Systemic · Anti-aging vs Recovery.

Related comparisons